References
- Bergers G, Benjamin LE. 2003. Tumorigenesis and the angiogenic switch. Nature Reviews Cancer 3:401–410.
- Bergers G, Hanahan D. 2008. Modes of resistance to anti-angiogenic therapy. Nature Reviews Cancer 8:592–603.
- Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al 1998. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490.
- Dewhirst MW, Cao Y, Moeller B. 2008. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nature Reviews Cancer 8:425–437.
- Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155–1159.
- Kallinowski F, Tyler G, Mueller-Klieser W, Vaupel P. 1989. Growth-related changes of oxygen consumption rates of tumor cells grown in vitro and in vivo. Journal of Cellular Physiology 138:183–191.
- Mayer A, Höckel M, Wree A, Leo C, Horn LC, Vaupel P. 2008. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Research 68:4719–4726.
- Mayer A, Höckel M, Wree A, Vaupel P. 2005. Microregional expression of glucose transporter-1 and oxygenation status: Lack of correlation in locally advanced cervical cancers. Clinical Cancer Research 11:2768–2773.
- Mayer A, Wree A, Höckel M, Leo C, Pilch H, Vaupel P. 2004. Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Research 64:5876–5881.
- Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Yothers. 2005. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nature Medicine 11:992–997.
- Mizukami Y, Kohgo Y, Chung DC. 2007. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clinical Cancer Research 13:5670–5674.
- Moeller BJ, Cao Y, Li CY, Dewhirst MW. 2004. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5:429–441.
- Ryan HE, Lo J, Johnson RS. 1998. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO Journal 17:3005–3015.
- Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. 2000. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Research 60:4010–4015.
- Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 3:721–732.
- Sullivan R, Graham CH. 2007. Hypoxia-driven selection of the metastatic phenotype. Cancer and Metastasis Reviews 26:319–331.
- Sullivan R, Pare GC, Frederiksen LJ, Semenza GL, Graham CH. 2008. Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Molecular Cancer Therapeutics 7:1961–1973.
- Vaupel P, Kallinowski F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Research 49:6449–6465.
- Vaupel P, Mayer A. 2007. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer and Metastasis Reviews 26:225–239.
- West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M. 2001. Tumour vascularity: A histological measure of angiogenesis and hypoxia. Cancer Research 61:2907–2910.
- Wouters BG, Koritzinsky M. 2008. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews Cancer 8:851–864.
- Zywietz F. 1990. Vascular and cellular damage in a murine tumour during fractionated treatment with radiation and hyperthermia. Strahlentherapie und Onkologie 166:493–501.
- Zywietz F, Reeker W, Kochs E. 1995. Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. International Journal of Radiation Oncology Biology Physics 32:1391–1400.